Evidence map›Paper›PMID 40731908›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors.

Zehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu, Mehmet Beşiroğlu, Ayşe İrem Yasin, Atakan Topçu, Melih Şimşek, Mesut Şeker, Hacı Mehmet Türk

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zehra Sucuoğlu İşleyenDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.ORCID 0000-0002-0045-8009
Harun MuğluDepartment of Medical Oncology, Medipol University Hospital, 34214 Istanbul, Turkey.ORCID 0000-0001-9584-0827
Zeynep Alaca TopçuDepartment of Medical Oncology, Istanbul Medeniyet University Hospital, 34722 Istanbul, Turkey.
Mehmet BeşiroğluDepartment of Medical Oncology, Istanbul Medeniyet University Hospital, 34722 Istanbul, Turkey.
Ayşe İrem YasinDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.
Atakan TopçuDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.
Melih ŞimşekDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.ORCID 0000-0003-0633-8558
Mesut ŞekerDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.
Hacı Mehmet TürkDepartment of Medical Oncology, Bezmialem Vakif University Hospital, 34093 Istanbul, Turkey.ORCID 0000-0003-2206-8148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6AdultAgedAged, 80 and overAminopyridinesCross-Sectional StudiesFemaleHumansKi-67 AntigenMiddle AgedPiperazinesProtein Kinase InhibitorsPurinesPyridinesAminopyridinesCDK4 protein, humanCDK6 protein, humanCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Ki-67 AntigenpalbociclibPiperazinesProtein Kinase InhibitorsPurinesPyridinesribociclibCDK 4/6 inhibitorsmetastatic breast cancerpalbociclibribociclib

Identifiers

PMID40731908
PMCPMC12299708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.